Friday, March 25, 2016

Under Analyst's Radar: Inovio Pharmaceuticals, Inc. (INO)

The company has collaborative development agreements with GeneOne Life Sciences to co-develop an Ebola vaccine through Phase I clinical trials; … Full Article http://j.gs/5sTq

Click here to read full article
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)